SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...
TORONTO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...
Medicare's initial drug negotiations yielded savings between 38% and 79% off list prices, sparking a new regulatory push by ...
TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...
IRVING, Texas & DENVER--(BUSINESS WIRE)--Vizient Inc. and RISCS, Inc. today announced a joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program would ...
PLEASANTON, Calif., Sept. 3, 2020 /PRNewswire/ -- Today, Surface Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics in eye ...
Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a biotechnology company developing a proprietary gel-based delivery platform for pharmaceutical, animal health and consumer health ...